Gleneagles Hong Kong is set to transform preventive care as the city’s first hospital network to offer a groundbreaking AI-powered longevity service.
Launching in Q1 2026, this cutting-edge technology from Quantum Life uses a single blood sample to analyse a patient’s entire genome, epigenetic markers, and clinical history.
Patients will receive a detailed report combining whole-genome sequencing which screens for inherited conditions, cancer predispositions, medication responses and polygenic risks for diseases such as Alzheimer’s and hypertension. With an epigenetic assessment that reveals the true biological age of individual organs and how lifestyle, stress and environment are accelerating or slowing aging, the programme aims to assist patients manage their health through tailored strategies rather than one-size-fits-all advice.
Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “At Gleneagles, we see innovation and technology as essential to shaping the future of healthcare. Over the years, we have been working with various health-tech partners to bring innovative solutions to our patients. This strategic collaboration with Quantum Life integrates AI and advanced multi-omics clinical analyses, which include genomics and epigenetics, into our services, enabling our patients to gain personalised health insights that support informed decisions and help prevent diseases before they develop. We believe this new service will set a new benchmark for personalised care.”
Starting at Gleneagles Medical Clinics in Central and Wong Chuk Hang, specially trained doctors will translate these insights into personalised prevention plans, spanning lifestyle changes to early medical interventions.
This initiative from Gleneagles Hong Kong sets a new benchmark for precision medicine, helping our patients stay healthier, longer.
Related Stories
Fortis Leads the Way in Building a Nation of First Responders
When a cardiac emergency strikes, survival often depends on what happens in the first few minutes. Before an ambulance arrives. Before hospital doors open. In those moments, a trained bystander can mean the difference between life and loss.
.png?sfvrsn=36e1af94_1)
Fortis Hospital Bannerghatta Road Successfully Treats Rare Nasal Tumour in Teen
After nearly two years of misdiagnosis, a 14-year-old boy suffering from a rare nasal tumour found a new lease of life at Fortis Hospital Bannerghatta Road.
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Fortis Charts the Future of Haematology
On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
